about
Hyperbaric oxygen therapy for multiple sclerosisN-acetyl-L-cysteine ameliorates the inflammatory disease process in experimental autoimmune encephalomyelitis in Lewis ratsThe therapeutic potential of HDAC inhibitors in the treatment of multiple sclerosisProteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.Benign course in multiple sclerosis: a review.Early stage and long term treatment of multiple sclerosis with interferon-betaMethylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis.The emerging role of p38 mitogen-activated protein kinase in multiple sclerosis and its models.Review of studies that have used knockout mice to assess normal function of prion protein under immunological or pathophysiological stress.Absence of the cellular prion protein exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyelitis.Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in ratsHypothalamic-pituitary-adrenal axis function and cytokine production in multiple sclerosis with or without interferon-beta treatment.Steroid therapy altered serum levels of CCL2 and CCL5 chemokines in multiple sclerosis patients during relapse.Reductions in neuronal peroxisomes in multiple sclerosis grey matter.Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model.Blockade of the kinin B1 receptor affects the cytokine/chemokine profile in rat brain subjected to autoimmune encephalomyelitis.Management Strategies to Facilitate Optimal Outcomes for Patients Treated with Delayed-release Dimethyl Fumarate.Active liver X receptor signaling in phagocytes in multiple sclerosis lesions.High fat diet exacerbates neuroinflammation in an animal model of multiple sclerosis by activation of the Renin Angiotensin system.
P2860
Q24247373-DFD047E2-5A9E-4651-937F-15C2A187950BQ24802262-46967835-EA16-449B-BFAF-812A7155CA7CQ35016997-B02C58E4-8C5E-4477-BFD5-7CC4D87BBBD9Q36228251-B3A30E48-5B87-4B33-9460-BF2DF163363BQ36468278-E00E9FDF-D833-4C99-8DBE-F09B01A7F72DQ37303237-0F903751-0FEB-4D8A-94C4-AECC294F75C6Q37690997-6F91ADDA-E892-4308-90A2-A42CD2262590Q38125129-51FFB238-3513-4AFF-BC84-86B2A5EE521DQ38215344-5B1E7470-3B2C-4B84-9E7D-ECFEF609CB5EQ42046092-746BEE70-2F2D-4302-BBF6-881D81E88A3EQ42161912-38BC2414-D1A6-49B2-BEC0-161B6BBE7425Q42520744-86A2247C-F392-45FF-B435-88852B2DEFDEQ45154866-8D570685-1CEC-405B-A7B0-5EBED37D075FQ46990344-356FAAE6-A75E-480B-9C2E-9B6143035137Q47655490-5810E5D9-62AA-4877-84B8-74FB47D88A86Q48324890-CF1984C3-9ADA-4BEB-90E5-B2D8FC29C52CQ50016769-93E9F2F4-CD1C-4990-81BF-689078552A01Q50855225-62B14B75-C028-4434-9AB2-EC149E0B010FQ54241919-7083E912-E61B-41C4-A444-CE6D9C06F2EB
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Molecular pathogenesis of multiple sclerosis.
@ast
Molecular pathogenesis of multiple sclerosis.
@en
type
label
Molecular pathogenesis of multiple sclerosis.
@ast
Molecular pathogenesis of multiple sclerosis.
@en
prefLabel
Molecular pathogenesis of multiple sclerosis.
@ast
Molecular pathogenesis of multiple sclerosis.
@en
P2093
P1476
Molecular pathogenesis of multiple sclerosis.
@en
P2093
Anderson DE
Oliveira EM
P304
P356
10.1016/S0165-5728(99)00193-9
P577
1999-12-01T00:00:00Z